scholarly article | Q13442814 |
P356 | DOI | 10.1373/CLINCHEM.2010.161265 |
P698 | PubMed publication ID | 21807867 |
P50 | author | Hugo A. Katus | Q27929168 |
Mehrshad Vafaie | Q57003762 | ||
P2093 | author name string | Evangelos Giannitsis | |
Tzveta Kehayova | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1452-1455 | |
P577 | publication date | 2011-08-01 | |
P1433 | published in | Clinical Chemistry | Q849687 |
P1476 | title | Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction | |
P478 | volume | 57 |
Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
Q86836389 | Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study |
Q42330822 | Clinical utility of novel biomarkers in acute myocardial infarction |
Q35433105 | Copeptin is an independent predictor of diabetic heart disease and death |
Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
Q38213084 | Copeptin-marker of acute myocardial infarction |
Q37599608 | Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. |
Q37684756 | Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation |
Q38237059 | Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review |
Q28085167 | Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis |
Q35059506 | Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study |
Q44497204 | Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers |
Q45743912 | Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes |
Q92152497 | Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry |
Q35692595 | No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome |
Q47139588 | Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study |
Q59335278 | Prospective diagnostic and prognostic study of copeptin in suspected acute aortic syndromes |
Q56547325 | Retracted article: Concomitant measurement of copeptin and high-sensitivity troponin for fast and reliable rule out of acute myocardial infarction |
Q54365449 | Serum copeptin and midregion proadrenomedullin (MR-proADM) after an ultramarathon. |
Q36972479 | The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study |
Q34134378 | The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department |
Search more.